Tranquo-Puren en es it fr

Tranquo-Puren Brand names, Tranquo-Puren Analogs

Tranquo-Puren Brand Names Mixture

  • No information avaliable

Tranquo-Puren Chemical_Formula


Tranquo-Puren RX_link

Tranquo-Puren fda sheet

Tranquo-Puren msds (material safety sheet)

Tranquo-Puren MSDS

Tranquo-Puren Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Tranquo-Puren Molecular Weight

284.74 g/mol

Tranquo-Puren Melting Point


Tranquo-Puren H2O Solubility

Slightly soluble (50 mg/L)

Tranquo-Puren State


Tranquo-Puren LogP


Tranquo-Puren Dosage Forms

Tablets; Injectable solution

Tranquo-Puren Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Tranquo-Puren Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Tranquo-Puren Absorption

Essentially complete, with a bioavailability of 93%.

Tranquo-Puren side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Tranquo-Puren Patient Information

Tranquo-Puren Organisms Affected

Humans and other mammals